Aligning growth with compliance integrity
ALIGN is an operating model for hospice leaders. It treats compliance integrity and census growth as one system to be managed together, not as competing priorities that take turns winning.
Growth decisions and compliance decisions are the same decisions
In many hospices, operations and sales drive growth while clinical and compliance leaders are asked to catch problems afterward. That arrangement puts the people who protect eligibility and quality one step behind every decision that creates risk.
ALIGN gives clinical and compliance leadership an equal seat at the table. Each domain names where growth and integrity meet, what leaders should watch, and the regulation that sets the standard.
- Oct 1, 2025The Hospice Outcomes and Patient Evaluation (HOPE) tool replaced the Hospice Item Set for quality reporting. CMS Hospice Quality Reporting Program
- Jul 30, 2026The FY 2027 hospice final rule introduced the Service and Spending Variation Index (SSVI), a set of claims based measures of hospice service and spending patterns. FY 2027 Hospice Payment Rate Update final rule
- Every yearHospices that do not meet quality reporting requirements receive a 4 percentage point reduction to their annual payment update. 42 CFR 418.306; 42 CFR 418.312
Five places where growth and integrity meet
Each domain is a question a leadership team should be able to answer with evidence, not reassurance.
Admission Strategy
Are the patients we admit the patients the hospice benefit was designed to serve?
Where it breaks down
- The handoff from referral to clinical evaluation
- Diagnosis driven thinking instead of trajectory driven thinking
- Volume pressure that wears down clinical gatekeeping
What leaders watch
- A shared admission standard for sales and clinical teams
- Referral sources and their admission patterns
- Admissions that later end in live discharge
Regulatory anchor: 42 CFR 418.20, eligibility requirements; 42 CFR 418.25, admission to hospice care; applicable Local Coverage Determinations
Leadership Oversight
Do the people accountable for quality and compliance see what is happening in time to act?
Where it breaks down
- Clinical and compliance leaders reporting below operations and sales
- Quality data that reaches leaders after decisions are made
- Governing body oversight that exists on paper only
What leaders watch
- A QAPI program with measurable, tracked indicators
- Compliance committee minutes that show decisions and follow through
- Clear escalation paths from the field to the board
Regulatory anchor: 42 CFR 418.58, quality assessment and performance improvement; 42 CFR 418.100, organization and administration; OIG General Compliance Program Guidance (November 2023)
Infrastructure for Clinical Excellence
Will our documentation, workforce, and systems hold up as the census grows?
Where it breaks down
- Orientation that varies by market or by preceptor
- Competency assumed rather than validated
- Documentation that does not tell the patient's clinical story
What leaders watch
- A standardized nurse orientation with competency validation
- Documentation audits tied to eligibility and the plan of care
- Staffing and caseloads as markets open
Regulatory anchor: 42 CFR 418.100(g), training, including orientation; 42 CFR 418.104, clinical records
Governance of Eligibility
Is every certification and recertification a documented clinical decision we can defend?
Where it breaks down
- Recertifications that repeat the last note instead of showing change
- Interdisciplinary group meetings that review without deciding
- Face to face encounters completed late or without clinical findings
What leaders watch
- Physician narratives that reflect the clinical record
- Interdisciplinary group discussion of continued eligibility
- Patients with long lengths of stay and how their decline is documented
Regulatory anchor: 42 CFR 418.22, certification of terminal illness, including the face to face encounter; 42 CFR 418.56, interdisciplinary group and plan of care
Near Term Risk Monitoring
Would we see a problem in our own data before a surveyor, auditor, or contractor does?
Where it breaks down
- Reviewing outside data only after it is published
- Measures tracked separately by different departments
- No defined threshold that triggers action
What leaders watch
- Live discharge rates and length of stay patterns
- Service and Spending Variation Index results
- Quality reporting completeness and HOPE measure performance
Regulatory anchor: 42 CFR 418.58, QAPI data use; 42 CFR 418.312, quality reporting data submission
I built ALIGN from the questions I had to answer as a hospice executive, then tested it through doctoral study.
As a founding employee of a multistate hospice organization, I built its clinical, compliance, and training infrastructure from the ground up. ALIGN organizes what that work taught me about growing responsibly.
ALIGN is also the organizing architecture of my DNP scholarly project at Walden University. The project focuses on standardized hospice nurse orientation and competency development as one intervention within the larger goal of compliant hospice growth.
Ways to use the framework
ALIGN Admissions Assessment
A 90 minute session with your leadership team that uses ALIGN to review how referrals become admissions.
Readiness and fractional leadership
Accreditation readiness and part time clinical and compliance leadership, organized around the five domains.
ALIGN for your conference or team
Sessions on compliant hospice growth for state associations, national meetings, and leadership teams.
Which domain is keeping you up at night?
Tell me where your agency feels the most pressure, and we will start there.